NXTC Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: NextCure

NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results

25 days ago - By: NextCure

NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States

25 days ago - By: NextCure

NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States

2 months ago - By: NextCure

NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: NextCure

NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: The Motley Fool

NextCure (NXTC) Q2 Loss Widens 71%

3 months ago - By: NextCure

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

3 months ago - By: NextCure

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

4 months ago - By: Benzinga - Mentions: IVA PIII TTNP HCTI ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 months ago - By: Benzinga - Mentions: CNC ZYXI XTLB SRPT ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

4 months ago - By: Stocktwits

NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment

4 months ago - By: NextCure

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

4 months ago - By: NextCure

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

5 months ago - By: Stocktwits - Mentions: VTI VXF

NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline

5 months ago - By: NextCure

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

5 months ago - By: NextCure

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

5 months ago - By: NextCure

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

5 months ago - By: NextCure

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

6 months ago - By: Yahoo Finance - Mentions: GAP TAL GOOS GOOG ...

The Gap, Inc. (GAP) Is A “Star,” Says Jim Cramer

6 months ago - By: Yahoo Finance - Mentions: GOOS TAL AXP NVDA ...

Canada Goose Holdings Inc. (GOOS) Has Been “Terrific,” Says Jim Cramer

6 months ago - By: NextCure

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

6 months ago - By: NextCure

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

7 months ago - By: NextCure

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

7 months ago - By: NextCure

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

8 months ago - By: NextCure

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

8 months ago - By: NextCure

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

9 months ago - By: Stocktwits - Mentions: SHPH LPTX KURA ACET

Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe

10 months ago - By: NextCure

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

10 months ago - By: NextCure

NEXTCURE INC (NXTC) Stock News

NXTC Latest News, Press Relases and Analysis